Submit Release
Contact Us Journalists Sign Up Login
Submit Release
Login

Email This News Release

"Eyam Vaccines and Immunotherapeutics Reaches Agreement to License Next-Generation COVID-19 Vaccine Candidates from the University of British Columbia"

Your privacy is important to us. We will never share your email or other information with a third party.

Logo

24-7 Press Release Service

Telephone Hours
Monday to Friday
8:30am to 5:00pm PST
Toll Free
1-888-880-9539 Telephone
646-417-8294
US Address:
Smith Tower
Suite 1400 - 506 Second Avenue
Seattle, WA
98104, USA
Address:
Suite 203 - 901 West 3rd St.
North Vancouver, BC
V7P 3P9, Canada